Oncotype DX Recurrence Score of Special Subtypes of Breast Carcinoma

被引：0
|
作者：
Ozerdem, Ugur [1 ]
Tavassoli, Fattaneh [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
241
引用
收藏
页码：63A / 63A
页数：1
相关论文
共 50 条
  • [21] BreastPRS Prognostic Score Is Comparable to Oncotype DX Recurrence Score
    van Laar, R.
    D'Alfonso, T. M.
    Flinchum, R.
    Brown, N.
    Saint John, L.
    Shin, S. J.
    MODERN PATHOLOGY, 2013, 26 : 73A - 73A
  • [22] Prediction of Oncotype DX Recurrence Score by Evaluating the Peritumoral Tumor Budding in Early-stage Breast Carcinoma
    Chu, Jinah
    Do, Jeongeun
    Do, Sung-Im
    Kim, Hyun-Soo
    ANTICANCER RESEARCH, 2023, 43 (12) : 5563 - 5571
  • [23] Can Conventional Histopathologic Prognostic Parameters of Invasive Breast Carcinoma Predict the Oncotype DX™ Recurrence Score.
    Bose, S.
    Mannan, A. A. S. R.
    Rathgeh, T.
    MODERN PATHOLOGY, 2011, 24 : 29A - 29A
  • [24] Histopathologic variables predict Oncotype DX™ Recurrence Score
    Flanagan, Melina B.
    Dabbs, David J.
    Brufsky, Adam M.
    Beriwal, Sushil
    Bhargava, Rohit
    MODERN PATHOLOGY, 2008, 21 (10) : 1255 - 1261
  • [25] Relationship of histologic grade and histologic subtype with oncotype Dx recurrence score; retrospective review of 863 breast cancer oncotype Dx results
    Kamaljeet Singh
    Xin He
    Elizabeth T. Kalife
    Shahrzad Ehdaivand
    Yihong Wang
    C. James Sung
    Breast Cancer Research and Treatment, 2018, 168 : 29 - 34
  • [26] Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia
    Lindsay J. Collin
    Ming Yan
    Renjian Jiang
    Kevin C. Ward
    Brittany Crawford
    Mylin A. Torres
    Keerthi Gogineni
    Preeti D. Subhedar
    Samantha Puvanesarajah
    Mia M. Gaudet
    Lauren E. McCullough
    npj Breast Cancer, 5
  • [27] Invasive Lobular Carcinoma and Oncotype Dx®: Impact of Pathology and Recurrence Score on Treatment Plan
    Ross, D. S.
    Galman, L. C.
    Catalano, J.
    Tan, L. K.
    MODERN PATHOLOGY, 2012, 25 : 64A - 64A
  • [28] Clinical Impact of a Novel Model Predictive of Oncotype DX Recurrence Score in Breast Cancer
    Yamamoto, Shinya
    Chishima, Takashi
    Shibata, Yukako
    Harada, Fumi
    Takeuchi, Hideki
    Yamada, Akimitsu
    Narui, Kazutaka
    Misumi, Toshihiro
    Ishikawa, Takashi
    Endo, Itaru
    IN VIVO, 2021, 35 (04): : 2439 - 2444
  • [29] Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®
    Richard Buus
    Zsolt Szijgyarto
    Eugene F. Schuster
    Hui Xiao
    Ben P. Haynes
    Ivana Sestak
    Jack Cuzick
    Laia Paré
    Elia Seguí
    Nuria Chic
    Aleix Prat
    Mitch Dowsett
    Maggie Chon U. Cheang
    npj Breast Cancer, 7
  • [30] Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia
    Collin, Lindsay J.
    Yan, Ming
    Jiang, Renjian
    Ward, Kevin C.
    Crawford, Brittany
    Torres, Mylin A.
    Gogineni, Keerthi
    Subhedar, Preeti D.
    Puvanesarajah, Samantha
    Gaudet, Mia M.
    McCullough, Lauren E.
    NPJ BREAST CANCER, 2019, 5 (1)
12345